IMRIS Receives Regulatory Approval In Japan



    -- Asia-Pacific Expansion Continues --

    WINNIPEG, May 26 /CNW/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company")
today announced that it has gained regulatory approval from the Ministry of
Health in Japan for its intra-operative imaging system - IMRISneuro - and will
immediately commence marketing from its office in Tokyo. Japan is recognized
as the world's second largest market for high-end medical equipment after the
United States and represents an important new opportunity for IMRIS.
    "Clearance in Japan is another milestone in our efforts to grow our
customer base globally," said David Graves, CEO of IMRIS. "With projects in
China, India and Australia, and with sales capabilities throughout the
Asia-Pacific region, IMRIS is well placed to continue to increase its global
market penetration."
    IMRISneuro has become the surgical imaging solution of choice by
neurosurgeons around the world. The fully integrated surgical suite
incorporates a one-of-a-kind technology that allows the surgical team to scan
a patient with a high-field MRI during a procedure and obtain critical patient
information without ever moving the patient. The result is more timely
information enabling surgeons to make better decisions and improve patient
outcomes.
    In addition to IMRISneuro, IMRIS is also pursuing regulatory approval in
Japan and other regions for its recently introduced new product lines IMRISNV
and IMRIScardio which have already received CE Mark approval for the European
market.

    About IMRIS

    IMRIS (TSX: IM) is a global leader in providing fully integrated,
advanced imaging solutions that serve the neurosurgical, cardiovascular and
stroke management markets. The Company's flagship product IMRISneuro is in use
by leading neurosurgeons at world-class neuroscience centers around the globe.
For more information, visit www.imris.com.





For further information:

For further information: Media: Michael Robbie, Director, Marketing,
Tel: (204) 480-7696, Email: mrobbie@imris.com; Investors: Brad Woods,
Director, Investor Relations & Corporate Communications, Tel: (204) 480-7094,
Email: bwoods@imris.com

Organization Profile

IMRIS Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890